Yang Yufan, Liu Qiming, Liu Zhenjiang, Zhou Shenghua
Cardiac Catheterization Lab of Second Xiangya Hospital attached to Central South University, Changsha, Hunan, 410011, China.
Department of Cardiology of Second Xiangya Hospital attached to Central South University, Changsha, Hunan, 410011, China.
J Cardiovasc Electrophysiol. 2017 Jul;28(7):768-775. doi: 10.1111/jce.13236. Epub 2017 Jun 22.
The origin of pulmonary sinus cusp (PSC)-derived ventricular arrhythmia (VA) is a highly specialized anatomical structure; therefore, insertion of the radiofrequency ablation catheter tip to the target site to ensure safe ablation is a major challenge for clinicians.
To summarize ablation methods, and provide valuable experience for the treatment of PSC-derived VA with ablation.
A retrospective analysis and summary of the clinical data of 15 patients undergoing catheter ablation for PSC-derived VA in Cardiac Intervention Therapy Center, The Second Xiangya Hospital of Central South University between January 2013 and July 2015 was conducted.
For the 15 patients, the PSC-derived VA originated from the lower regions of the pulmonary sinuses, leading from the right, left, and anterior sinuses of the PSC in 4, 6, and 5 patients, respectively. Nine patients with PSC-derived VAs originating from the right and anterior sinuses underwent successful reversed U-curve catheter ablation, while the other six cases with arrhythmias originating from the left sinus underwent successful ablation with the conventional method (nonreversed U-curve catheter ablation). All the patients were followed-up for 6-31 months, and no cases of recurrence or complications occurred.
Reversed U-curve catheter ablation is suitable for VAs originating from the right and anterior PSCs, while conventional ablation can also be used for those originating from the left PSCs.
肺窦嵴(PSC)源性室性心律失常(VA)起源于高度特殊的解剖结构;因此,将射频消融导管尖端插入目标部位以确保安全消融对临床医生来说是一项重大挑战。
总结消融方法,为采用消融治疗PSC源性VA提供有价值的经验。
对2013年1月至2015年7月在中南大学湘雅二医院心脏介入治疗中心接受导管消融治疗PSC源性VA的15例患者的临床资料进行回顾性分析和总结。
15例患者中,PSC源性VA起源于肺窦下部,分别有4例、6例和5例起源于PSC的右窦、左窦和前窦。9例起源于右窦和前窦的PSC源性VA患者成功接受了反向U形曲线导管消融,另外6例起源于左窦的心律失常患者采用传统方法(非反向U形曲线导管消融)成功消融。所有患者均随访6 - 31个月,未出现复发或并发症病例。
反向U形曲线导管消融适用于起源于右和前PSC的VA,而传统消融也可用于起源于左PSC的VA。